These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 37180133)

  • 21. [Experience of biological therapy in severe forms of chronic rhinosinusitis with nasal polyps in the conditions of regional healthcare].
    Larin RA; Mokeeva PP; Grishin AS
    Vestn Otorinolaringol; 2023; 88(2):51-58. PubMed ID: 37184555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2 Biomarkers for the Indication and Response to Biologics in CRSwNP.
    Guo CL; Liu FF; Wang DY; Liu Z
    Curr Allergy Asthma Rep; 2023 Dec; 23(12):703-713. PubMed ID: 37987873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status.
    Fujieda S; Matsune S; Takeno S; Ohta N; Asako M; Bachert C; Inoue T; Takahashi Y; Fujita H; Deniz Y; Rowe P; Ortiz B; Li Y; Mannent LP
    Allergy; 2022 Jan; 77(1):186-196. PubMed ID: 33993501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps.
    Pelaia C; Benfante A; Busceti MT; Caiaffa MF; Campisi R; Carpagnano GE; Crimi N; D'Amato M; Foschino Barbaro MP; Maglio A; Minenna E; Nolasco S; Paglino G; Papia F; Pelaia G; Portacci A; Ricciardi L; Scichilone N; Scioscia G; Triggiani M; Valenti G; Vatrella A; Crimi C
    Front Immunol; 2023; 14():1121237. PubMed ID: 37063895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis.
    Fokkens W; Van Der Lans R; Reitsma S
    Expert Opin Biol Ther; 2021 May; 21(5):575-585. PubMed ID: 33724109
    [No Abstract]   [Full Text] [Related]  

  • 26. The roles of nasal nitric oxide in diagnosis and endotypes of chronic rhinosinusitis with nasal polyps.
    Zhu M; Gao X; Zhu Z; Hu X; Zhou H; Liu J
    J Otolaryngol Head Neck Surg; 2020 Sep; 49(1):68. PubMed ID: 32962755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clara cell protein 16 and eosinophil cationic protein production in chronically inflamed sinonasal mucosa.
    Špadijer-Mirković C; Perić A; Belić B; Vojvodić D
    Int Forum Allergy Rhinol; 2016 May; 6(5):529-36. PubMed ID: 26833624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
    Wechsler ME; Klion AD; Paggiaro P; Nair P; Staumont-Salle D; Radwan A; Johnson RR; Kapoor U; Khokhar FA; Daizadeh N; Chen Z; Laws E; Ortiz B; Jacob-Nara JA; Mannent LP; Rowe PJ; Deniz Y
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2695-2709. PubMed ID: 35636689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic significance of blood eosinophil count in eosinophilic chronic rhinosinusitis with nasal polyps in Chinese adults.
    Hu Y; Cao PP; Liang GT; Cui YH; Liu Z
    Laryngoscope; 2012 Mar; 122(3):498-503. PubMed ID: 22252861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?
    Al-Ahmad M; Ali A; Khalaf M; Alterki A; Rodriguez-Bouza T
    BMC Pulm Med; 2023 Jul; 23(1):266. PubMed ID: 37464395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months.
    van der Lans RJL; Otten JJ; Adriaensen GFJPM; Hoven DR; Benoist LB; Fokkens WJ; Reitsma S
    Allergy; 2023 Oct; 78(10):2684-2697. PubMed ID: 37394895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgE directly affects eosinophil migration in chronic rhinosinusitis with nasal polyps through CCR3 and predicts the efficacy of omalizumab.
    Yu J; Yan B; Shen S; Wang Y; Li Y; Cao F; Xiong W; Piao Y; Hu C; Sun Y; Zhang L; Wang C
    J Allergy Clin Immunol; 2024 Feb; 153(2):447-460.e9. PubMed ID: 37922997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
    Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
    Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Very Rapid Improvement in Extended Nitric Oxide Parameters Is Associated With Clinical and Functional Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps Treated With Dupilumab.
    Paoletti G; Casini M; Malvezzi L; Pirola F; Russo E; Nappi E; Muci GQ; Montagna C; Messina MR; Ferri S; Racca F; Lamacchia D; Cataldo G; Puggioni F; De Virgilio A; Ferreli F; Mercante G; Spriano G; Canonica GW; Heffler E
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):457-463. PubMed ID: 38095494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dupilumab for chronic rhinosinusitis with nasal polyps: real-life retrospective 12-month effectiveness data.
    Boscke R; Heidemann M; Bruchhage KL
    Rhinology; 2023 Jun; 61(3):203-213. PubMed ID: 36946589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of preoperative blood eosinophil counts in distinguishing chronic rhinosinusitis with nasal polyps phenotypes.
    Zhong B; Yuan T; Du J; Tan K; Yang Q; Liu F; Liu Y; Ba L; Liu S
    Int Forum Allergy Rhinol; 2021 Jan; 11(1):16-23. PubMed ID: 32634298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronic rhinosinusitis with nasal polyps-extension of dupilumab treatment intervals].
    Appel HM; Lochbaum R; Hoffmann TK; Hahn J
    HNO; 2024 Jul; 72(7):499-503. PubMed ID: 38761229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan.
    Fujieda S; Matsune S; Takeno S; Asako M; Takeuchi M; Fujita H; Takahashi Y; Amin N; Deniz Y; Rowe P; Mannent L
    Laryngoscope; 2021 Jun; 131(6):E1770-E1777. PubMed ID: 33226139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing the timing of biologic and surgical therapy for patients with refractory chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Garvey E; Naimi B; Duffy A; Hannikainen P; Kahn C; Farquhar D; Rosen M; Rabinowitz M; Toskala E; Nyquist G
    Int Forum Allergy Rhinol; 2024 Mar; 14(3):651-659. PubMed ID: 37506043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-utility analysis of dupilumab compared with endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyps. Evaluation in Colombia, a developing country.
    Alvarez L; Querubin J; Bedoya J; Mejia A; Sánchez J
    Expert Rev Pharmacoecon Outcomes Res; 2023 Jun; 23(5):571-578. PubMed ID: 36976904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.